

A non-executive director of FTSE 250 emergency repair group Homeserve has purchased his first lot of shares one month after joining the firm. Ben Mi...


Vectura Group, the company that specialises in the treatment of respiratory diseases, is reducing its research and development (R&D) expenditure by ar...


Unilever: Bank of America Merrill Lynch downgrades to underweight from neutral. Aggreko: Credit Suisse downgrades to neutral from outperform. Capit...


Analysts at Singer Capital write today that, "NVA237 (COPD) has been filed with Japanese regulators by Vectura's development partner Novartis. In addi...


Analysts at this broker write today that, "NVA237 (COPD) has been filed with Japanese regulators by Vectura's development partner Novartis. In additio...


Atkins WS: UBS reiterates neutral, raises price target to 600p from 560p. Johnson Matthey: UBS reiterates buy, ups target to 2015p from 1915p. Lloyd...


Two senior board members at Hammerson have both bought shares in the shopping centre operator, buying into weakness after a recent plummet in profits....


Inhaled pharmaceutical products maker Vectura has agreed a new US collaboration with a leading international pharmaceutical company. Under the terms...